Portal de Periódicos da CAPES

Evolving Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Esophageal Carcinoma

2006; Elsevier BV; Volume: 15; Issue: 4 Linguagem: Inglês

10.1016/j.soc.2006.07.013

1558-5042

Hung Q. Dam, Timothy M. Manzone, VIDYA V. SAGAR,

Lung Cancer Diagnosis and Treatment

Positron emission tomography (PTE) and PET/CT imaging with (18)F-fluorodeoxyglucose are metabolic imaging modalities that depict tissues based on their level of glucose uptake. PET provides useful information in the primary staging of disease. PET performance in detecting locoregional nodal metastases is limited; however, it is the most accurate single noninvasive modality for detecting distant metastases. It is the imaging modality of choice for whole-body scanning in high-risk patients or patients who have clinically suspected recurrence, and is particularly helpful in determining which patients are the best candidates for surgical cure.